Privia Health gets new 5.07% shareholder group

An investment group led by Puma Growth Holdings and Rubicon Founders has disclosed a 5.07% beneficial stake in Privia Health Group, Inc.

Rhea-AI Filing Summary

Privia Health Group, Inc. (PRVA) has a new significant shareholder group reporting a position in its common stock. Puma Growth Holdings, LLC and affiliated Rubicon Founders entities, together with Adam Boehler, report beneficial ownership of 6,472,513 shares of Privia common stock, representing 5.07% of the outstanding shares.

The group acquired Privia shares for investment purposes, using approximately $138.4 million of working capital. They state an intention to continue reviewing their investment and may communicate with Privia’s officers, directors, other stockholders, and third parties, which indicates an active-investor posture, though no specific plans or proposals are disclosed.

Filing Explained

The reported position remains 5.07% of Privia, with shared voting and disposition rights across the reporting chain.

This Schedule 13D reports that Puma Growth Holdings and related reporting persons beneficially own 6,472,513 Privia common shares, or 5.07%, with shared voting and dispositive power; the structural change is at the holder level, not an increase in Privia’s issued share count.

The Schedule 13D label is used for a holder that may seek to influence control, unlike Schedule 13G for a passive holder; here, the filing reports shared rather than sole voting and disposition power among the reporting chain.

Item 5 lists sales of 100,000 shares on July 7, 2026 and 97,557 on July 13, 2026, followed by purchases of 301,807 on August 6, 51,521 on August 24, 150,005 on August 25, 100,000 on August 27, and 95,658 on September 1; the reported percentage uses 127,734,207 shares outstanding as of July 31, 2026.

Key Figures

Beneficial ownership: 6,472,513 shares Ownership percentage: 5.07% Shares outstanding: 127,734,207 shares +5 more

8 metrics

Beneficial ownership 6,472,513 shares Common stock of Privia Health Group, Inc. reported as beneficially owned

Ownership percentage 5.07% Portion of Privia common stock class represented by the reported holdings

Shares outstanding 127,734,207 shares Privia common stock issued and outstanding as of July 31, 2026

Aggregate purchase price $138,436,812 Approximate amount of working capital used to buy the reported Privia shares

Sale transaction 100,000 shares at $27.21 Common stock sold on July 7, 2026

Sale transaction 97,557 shares at $27.65 Common stock sold on July 13, 2026

Purchase transaction 301,807 shares at $20.98 Common stock purchased on August 6, 2026

Purchase transaction 95,658 shares at $20.91 Common stock purchased on September 1, 2026, the event date

Key Terms

beneficially owned, shared Voting Power, shared Dispositive Power, working capital, +1 more

5 terms

beneficially owned financial

"for the aggregate number of shares of Common Stock and percentage of the Common Stock beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared Voting Power financial

"Shared Voting Power 6,472,513.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared Dispositive Power financial

"Shared Dispositive Power 6,472,513.00"

working capital financial

"was purchased using working capital of the Reporting Persons or their affiliates"

Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.

Joint Filing Agreement regulatory

"Other than the Joint Filing Agreement attached as Exhibit A hereto"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Privia Health Group, Inc. (PRVA) does the reporting group own?

The reporting group beneficially owns 6,472,513 shares of Privia Health Group, Inc. common stock, representing 5.07% of the class, based on 127,734,207 shares outstanding as of July 31, 2026.

Who are the investors reporting this 5.07% stake in PRVA?

The reporting persons are Puma Growth Holdings, LLC, Rubicon Founders OP GP, LP, Rubicon Founders OP GP 2 LLC, Rubicon Founders LLC, and Adam Boehler, which are affiliated investment and investment-management entities and an individual investor.

How much have the reporting persons invested in PRVA shares?

The reporting persons state that they used an aggregate of approximately $138,436,812 of working capital (excluding brokerage commissions) to purchase the Privia Health Group, Inc. common stock they report as beneficially owned.

What recent trading activity in PRVA shares did the reporting group disclose?

They reported selling 100,000 shares at $27.21 on July 7, 2026 and 97,557 shares at $27.65 on July 13, 2026, then buying multiple blocks, including 301,807 shares at $20.98 on August 6, 2026 and 95,658 shares at $20.91 on September 1, 2026.

What is the stated purpose of the reporting group’s investment in PRVA?

The investors state they acquired Privia Health Group, Inc. common stock for investment purposes. They intend to review their investment on an ongoing basis and may communicate with company officers, directors, other stockholders, and third parties, but disclose no specific plans or proposals.

Do the reporting persons have shared or sole voting power over their PRVA shares?

Each reporting person reports 0 shares with sole voting power and 6,472,513 shares with shared voting power, and similarly 0 shares with sole dispositive power and 6,472,513 shares with shared dispositive power over Privia Health Group, Inc. common stock.

Are there any special contracts or derivative positions related to the PRVA stake?

They state that, other than a Joint Filing Agreement, there are no contracts, arrangements, understandings or relationships regarding Privia securities, including options, security-based swaps, or other derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 02:51 PM EDT Accepted by SEC EDGAR 09/08/2026 - 02:48 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Privia Health Group, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

74276R102

(CUSIP Number)

Cory Reno
1316 Adams St., Suite 400
Nashville, TN, 37208
1.615.568.7618

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

09/01/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 74276R102

1

Name of reporting person

Puma Growth Holdings, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,472,513.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,472,513.00

11

Aggregate amount beneficially owned by each reporting person

6,472,513.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.07 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP Number(s): 74276R102

1

Name of reporting person

Rubicon Founders OP GP, LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,472,513.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,472,513.00

11

Aggregate amount beneficially owned by each reporting person

6,472,513.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.07 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) Consists of shares owned by Puma Growth Holdings, LLC, of which Rubicon Founders OP GP, LP is the manager.

SCHEDULE 13D

CUSIP Number(s): 74276R102

1

Name of reporting person

Rubicon Founders OP GP 2 LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,472,513.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,472,513.00

11

Aggregate amount beneficially owned by each reporting person

6,472,513.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.07 %

14

Type of Reporting Person (See Instructions)

EP, OO

Comment for Type of Reporting Person:

(1) Consists of shares owned by Puma Growth Holdings, LLC. Rubicon Founders OP GP, LP, of which Rubicon Founders OP GP 2, LLC is the general partner, is the manager of Puma Growth Holdings, LLC.

SCHEDULE 13D

CUSIP Number(s): 74276R102

1

Name of reporting person

Rubicon Founders LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,472,513.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,472,513.00

11

Aggregate amount beneficially owned by each reporting person

6,472,513.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.07 %

14

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person:

(1) Consists of shares owned by Puma Growth Holdings, LLC. Rubicon Founders OP GP 2, LLC, of which Rubicon Founders LLC is the sole member, is the general partner of Rubicon Founders OP GP, LP, which is the manager of Puma Growth Holdings, LLC.

SCHEDULE 13D

CUSIP Number(s): 74276R102

1

Name of reporting person

Adam Boehler

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

AF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 6,472,513.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 6,472,513.00

11

Aggregate amount beneficially owned by each reporting person

6,472,513.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.07 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

(1) Consists of shares owned by Puma Growth Holdings, LLC. Rubicon Founders LLC, of which Mr. Boehler is the managing member, is the sole member of Rubicon Founders OP GP 2, LLC, which is the general partner of Rubicon Founders OP GP, LP, which is the manager of Puma Growth Holdings, LLC.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock
(b)	Name of Issuer: Privia Health Group, Inc.
(c)	Address of Issuer's Principal Executive Offices: 950 N. Glebe Rd., Suite 700, Arlington, VIRGINIA , 22203.
Item 2.	Identity and Background
(a)	Puma Growth Holdings, LLC, a Delaware limited liability company ("Puma"), Rubicon Founders OP GP, LP, a Delaware limited partnership ("RF OP GP"), Rubicon Founders OP GP 2 LLC, a Delaware limited liability company ("RF OP GP 2"), Rubicon Founders LLC, a Delaware limited liability company ("Rubicon Founders"), and Adam Boehler
(b)	1316 Adams St., Suite 400, Nashville, TN 37208
(c)	The principal business of each of the Reporting Persons is investment and/or investment management.
(d)	During the five years preceding the date of this filing, none of the Reporting Persons nor, to the best of the Reporting Persons' knowledge, any of the Related Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	During the five years preceding the date of this filing, none of the Reporting Persons nor, to the best of the Reporting Persons' knowledge, any of the Related Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	The Reporting Persons (other than Mr. Boehler). are organized under the laws of the state of Delaware. Mr. Boehler is a United States citizen.
Item 3.	Source and Amount of Funds or Other Consideration
	The Common Stock reported herein as being beneficially owned by the Reporting Persons was purchased using working capital of the Reporting Persons or their affiliates. An aggregate of approximately $138,436,812 (excluding brokerage commissions) was used to purchase the Common Stock reported as beneficially owned by the Reporting Persons in this Schedule 13D.
Item 4.	Purpose of Transaction
	The Reporting Persons originally acquired the Common Stock reported herein for investment purposes because they believed such shares represented an attractive investment opportunity. The Reporting Persons intend to review their investments in the Issuer on a continuing basis and in connection with such review communicate with officers and directors of the Issuer or other stockholders or third parties, such as industry analysts, existing or potential strategic partners, investment professionals and other investors.
Item 5.	Interest in Securities of the Issuer
(a)	See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of shares of Common Stock and percentage of the Common Stock beneficially owned by each of the Reporting Persons. The percentages reported in this Schedule 13D were calculated based on a total of 127,734,207 shares of Common Stock issued and outstanding as of July 31, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on August 6, 2026.
(b)	See rows (7) through (10) of the cover pages to this Schedule 13D for the number of shares of Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
(c)	Type of Transaction Shares of Common Stock Purchased/Sold Price Per Share Date of Purchase Sell 100,000 $27.21 07/07/2026 Sell 97,557 $27.65 07/13/2026 Buy 301,807 $20.98 08/06/2026 Buy 51,521 $21.00 08/24/2026 Buy 150,005 $20.98 08/25/2026 Buy 100,000 $20.90 08/27/2026 Buy 95,658 $20.91 09/01/2026
(d)	Other than the Reporting Persons, no other person is known to have the right to receive, or the power to direct the receipt of, dividends from or proceeds from the sale, of the Common Stock.
(e)	N/A
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Other than the Joint Filing Agreement attached as Exhibit A hereto, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among any Reporting Person or between such persons and any person with respect to any securities of the Issuer, including any class of the Issuer's securities used as a reference security, in connection with any of the following: call options, put options, security-based swaps or any other derivative securities, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.
Item 7.	Material to be Filed as Exhibits.
	Exhibit A, Joint Filing Agreement

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Puma Growth Holdings, LLC

Signature:	/s/ Cory Reno
Name/Title:	Cory Reno
Date:	09/08/2026

Rubicon Founders OP GP, LP

Signature:	/s/ Cory Reno
Name/Title:	Cory Reno
Date:	09/08/2026

Rubicon Founders OP GP 2 LLC

Signature:	/s/ Cory Reno
Name/Title:	Cory Reno
Date:	09/08/2026

Rubicon Founders LLC

Signature:	/s/ Cory Reno
Name/Title:	Cory Reno
Date:	09/08/2026

Adam Boehler

Signature:	/s/ Adam Boehler
Name/Title:	Adam Boehler
Date:	09/08/2026